Skip to main content

Table 2 Molecular definition of drug-resistance according to participant countries

From: Host candidate gene polymorphisms and clearance of drug-resistant Plasmodium falciparum parasites

Country

Definition of genotypic resistance to:

Chloroquine

SP

Other

Burkina Faso

Pfcrt76 T

Dhfr51 I/59 R/108 N

 

Cameroon (Yaoundé)

n/a

Dhfr51 I/59 R/108 N + Dhps437 G

AQ: Pfcrt76 T + Pfmdr1-86 Y

Kenya

Pfcrt76 T

Dhfr108 N + one or more of Dhfr51 I, Dhfr59 R, Dhps436 A, Dhps540 E

 

Mali

Pfcrt76 T

Dhfr51 I/59 R/108 N

 

Sudan

Pfcrt76 T + Pfmdr1-86 Y

Dhfr51 I/108 N + Dhps437 G/540 E

 
  1. Mutations in Pfcrt and Pfmdr1 were considered for resistance to chloroquine, and in dhfr and dhps for resistance to SP. SP = sulfadoxine-pyrimethamine AQ = amodiaquine. n/a = not applicable.